These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 268657)

  • 21. [Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].
    Kalies I; Kalden JR; Heinz F; Janzen RW; Lachenmayer L
    Klin Wochenschr; 1979 Sep; 57(17):875-81. PubMed ID: 502355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.
    Drachman DB; Angus CW; Adams RN; Michelson JD; Hoffman GJ
    N Engl J Med; 1978 May; 298(20):1116-22. PubMed ID: 643030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple forms of anti-acetylcholine receptor antibody in myasthenia gravis.
    Mittag T; Massa T; Kornfeld P; Papatestas A; Bender A; Genkins G
    Muscle Nerve; 1981; 4(1):16-25. PubMed ID: 6164920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The developmental change in immunological properties of the acetylcholine receptor in rat muscle.
    Reiness CG; Hall ZW
    Dev Biol; 1981 Jan; 81(2):324-31. PubMed ID: 6162693
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
    Uchitel O; Engel AG; Walls TJ; Nagel A; Atassi MZ; Bril V
    Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic studies on neurotoxin-binding inhibitory antibodies in myasthenia gravis.
    Ito A; Furukawa S; Satoyoshi E; Sakurai H
    Clin Chim Acta; 1985 Nov; 152(3):315-23. PubMed ID: 2998645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 30. Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspects.
    Burres SA; Crayton JW; Gomez CM; Richman DP
    Ann Neurol; 1981 Jun; 9(6):563-8. PubMed ID: 6167199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
    Berman PW; Heinemann SF
    J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody to acetylcholine receptor: cell line established from thymus of patient with Myasthenia gravis.
    Kamo I; Furukawa S; Tada A; Mano Y; Iwasaki Y; Furuse T; Ito N; Hayashi K; Satoyoshi E
    Science; 1982 Feb; 215(4535):995-7. PubMed ID: 6297000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.
    Drachman DB; Adams RN; Josifek LF; Self SG
    N Engl J Med; 1982 Sep; 307(13):769-75. PubMed ID: 7110241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and assay of antibodies to acetylcholine receptors.
    Lindstrom J; Einarson B; Tzartos S
    Methods Enzymol; 1981; 74 Pt C():432-60. PubMed ID: 7321891
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholine receptor turnover in mice with passively transferred myasthenia gravis. I. Receptor degradation.
    Wilson S; Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):377-82. PubMed ID: 6101171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of a myasthenic serum on the acetylcholine receptors of C2 myotubes. II. Functional inactivation of the receptor.
    Maricq AV; Gu Y; Hestrin S; Hall Z
    J Neurosci; 1985 Jul; 5(7):1917-24. PubMed ID: 2410577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.
    Kaplan I; Blakely BT; Pavlath GK; Travis M; Blau HM
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):8100-4. PubMed ID: 2236023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of myasthenic serum globulin with the acetylcholine receptor.
    Almon RR; Appel SH
    Biochim Biophys Acta; 1975 May; 393(1):66-77. PubMed ID: 1138925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholine receptor turnover in myasthenia gravis.
    Appel SH; Blosser JC; McManaman JL; Ashizawa T
    Am J Physiol; 1982 Jul; 243(1):E31-6. PubMed ID: 7091363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.